Deferoxamine [clinicaltrials_resource:fdd76580b2ea28dc5f05ac8c71ad4ecb]
Evaluation of Subcutaneous Desferrioxamine as Treatment for Transfusional Hemochromatosis [clinicaltrials:NCT00000595]Thalassemia (Cooley's Anemia) Clinical Research Network (TCRN) [clinicaltrials:NCT00000623]Deferoxamine for the Treatment of Hemochromatosis [clinicaltrials:NCT00001203]Safety & Efficacy of ICL670 vs. Deferoxamine in Beta-thalassemia Patients With Iron Overload Due to Blood Transfusions [clinicaltrials:NCT00061750]Study of Deferasirox in Iron Overload From Beta-thalassemia Unable to be Treated With Deferoxamine or Chronic Anemias [clinicaltrials:NCT00061763]Safety of ICL670 vs. Deferoxamine in Sickle Cell Disease Patients With Iron Overload Due to Blood Transfusions [clinicaltrials:NCT00067080]Combined Chelation Treatment With Deferiprone and Deferoxamine in Thalassemia Major [clinicaltrials:NCT00103753]Efficacy Study in Removing Excess Iron From the Heart [clinicaltrials:NCT00105495]clinicaltrials:NCT00110617clinicaltrials:NCT00115349Study Using Deferiprone Alone or in Combination With Desferrioxamine in Iron Overloaded Transfusion-dependent Patients [clinicaltrials:NCT00349453]Study With Deferiprone and/or Desferrioxamine in Iron Overloaded Patients [clinicaltrials:NCT00350662]clinicaltrials:NCT00598572clinicaltrials:NCT00600938clinicaltrials:NCT00658411Efficacy Study of the Use of Sequential DFP-DFO Versus DFP [clinicaltrials:NCT00733811]clinicaltrials:NCT00738413Pilot Study for Patients With Poor Response to Deferasirox [clinicaltrials:NCT00749515]clinicaltrials:NCT00777140Intensive Combined Chelation Therapy for Iron-Induced Cardiac Disease in Patients With Thalassemia Major [clinicaltrials:NCT00800761]N-acetylcysteine Plus Deferoxamine for Patients With Hypotension [clinicaltrials:NCT00870883]Combo Chelation Trial [clinicaltrials:NCT00901199]clinicaltrials:NCT00999349clinicaltrials:NCT01090323clinicaltrials:NCT01254227Modulation of Cerebral Blood Flow Using Iron Chelators [clinicaltrials:NCT01365104]Efficacy and Safety of Desferal Versus Osveral in Transfusional Iron Overload [clinicaltrials:NCT01369719]clinicaltrials:NCT01459718Study Of Efficacy,Safety of Combined Deferasirox and Deferiprone Versus Combined Deferiprone and Desferal In Conditions of Iron Overload [clinicaltrials:NCT01511848]clinicaltrials:NCT01662895Immunomodulatory Effects of Silymarin in Patients With Beta-Thalassemia Major [clinicaltrials:NCT01752153]Efficacy and Safety of Efficacy and Safety of Continued Iron Chelation Therapy In Poly-transfused Thalassemia Patients With Low Serum Ferritin (< 500 ng/ml) [clinicaltrials:NCT01996683]clinicaltrials:NCT02041299clinicaltrials:NCT02175225clinicaltrials:NCT02216513clinicaltrials:NCT02367248
intervention browse [clinicaltrials_vocabulary:intervention-browse]
Deferoxamine [clinicaltrials_resource:fdd76580b2ea28dc5f05ac8c71ad4ecb]
Bio2RDF identifier
fdd76580b2ea28dc5f05ac8c71ad4ecb
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:fdd76580b2ea28dc5f05ac8c71ad4ecb
identifier
clinicaltrials_resource:fdd76580b2ea28dc5f05ac8c71ad4ecb
title
Deferoxamine
@en
type
label
Deferoxamine [clinicaltrials_resource:fdd76580b2ea28dc5f05ac8c71ad4ecb]
@en